Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | ADK | P55263 | 2/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | STAT6 | P42226 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14111466 | 0.92 | ADORA3 (0.36) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111534 | 0.91 | ADORA2A (0.36) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111457 | 0.90 | ADORA3 (0.38) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111456 | 0.90 | HIF1A (0.44) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111464 | 0.89 | ADORA3 (0.37) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111587 | 0.88 | ADORA2A (0.35) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111475 | 0.86 | ADORA3 (0.37) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111441 | 0.85 | ADORA2A (0.46) | ADORA2AADKPAX8 | |
| SCHEMBL14111460 | 0.83 | ADORA3 (0.38) | ADORA2AADORA3ADORA1ADORA2BADK | |
| SCHEMBL14111462 | 0.82 | TMEM97 (0.46) | ADORA2AADORA3ADORA1ADORA2BADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405204-B2 | Nucleoside compounds for treating viral infections | GENELABS TECHNOLOGIES, INC. (US) | 2008-07-29 | — | — | US | disclosed |